Join

Compare · BBDC vs SWKH

BBDC vs SWKH

Side-by-side comparison of Barings BDC Inc. (BBDC) and SWK Holdings Corporation (SWKH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BBDC and SWKH operate in Diversified Financial Services (Finance), so they compete in similar markets.
  • BBDC is the larger of the two at $917.2M, about 3.8x SWKH ($242.4M).
  • Over the past year, BBDC is down 5.5% and SWKH is up 12.1% - SWKH leads by 17.6 points.
  • BBDC has hit the wire 2 times in the past 4 weeks while SWKH has been quiet.
  • BBDC has more recent analyst coverage (8 ratings vs 2 for SWKH).
PerformanceBBDC-4.41%SWKH+12.11%
2025-08-01+0.00%2026-06-02
MetricBBDCSWKH
Company
Barings BDC Inc.
SWK Holdings Corporation
Price
$8.77-1.02%
$15.92-6.46%
Market cap
$917.2M
$242.4M
1M return
-4.98%
-2.45%
1Y return
-5.50%
+12.11%
Industry
Diversified Financial Services
Diversified Financial Services
Exchange
NYSE
NASDAQ
IPO
News (4w)
2
0
Recent ratings
8
2
BBDC

Barings BDC Inc.

Barings BDC, Inc. (NYSE: BBDC) is a publicly traded, externally managed investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. Barings BDC seeks to invest primarily in senior secured loans to private U.S. middle-market companies that operate across a wide range of industries. It specializes in mezzanine, leveraged buyouts, management buyouts, ESOPs, change of control transactions, acquisition financings, growth financing, and recapitalizations in lower middle market, mature, and later stage companies. Barings BDC's investment activities are managed by its investment adviser, Barings LLC, a leading global asset manager based in Charlotte, NC with over $335 billion of AUM firm-wide. For more information, visit www.baringsbdc.com.

SWKH

SWK Holdings Corporation

SWK Holdings Corporation, a specialty finance company, focuses on the healthcare sector. The company operates in two segments, Finance Receivables and Pharmaceutical Development. It provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. The company, through its subsidiary, SWK Advisors LLC, offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The company also engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Its product pipeline includes Ovarest, an oral leuprolide tablet to treat endometriosis; and Tobrate, an oral tobramycin tablet for the treatment of uncomplicated urinary tract infections. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.

Latest BBDC

Latest SWKH